Using SELDI technology from Ciphergen, researchers at Johns Hopkins University have identified three protein biomarkers that when combined with the standard CA125 biomarker detected early-stage ovarian cancer in 74 percent of women study patients who had the disease.

The new biomarkers, the latest in a wave of new proteomic biomarker discoveries in this area (See PM 06-11-04), can potentially be developed further as a diagnostic to improve detection of early-stage ovarian cancer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jul
12
Sponsored by
Canon BioMedical

This webinar will discuss a project that is analyzing the “Human Brainome” – genome, transcriptome, proteome, and phenome interaction data -- to gain insights into Alzheimer’s disease pathogenesis.